dementia

dementia
Field	Neurology, Geriatrics, Psychiatry

dementia is a syndrome characterized by a progressive decline in cognitive function severe enough to interfere with daily life. It is not a single disease but a general term encompassing a range of specific medical conditions, most commonly Alzheimer's disease. The syndrome involves impairments in areas such as memory, thinking, orientation, comprehension, calculation, learning capacity, language, and judgement, often accompanied by changes in mood and behavior.

Signs and symptoms

Early signs often include increasing forgetfulness and losing track of time, which may progress to disorientation in familiar places like one's own neighborhood. Individuals may experience difficulty with communication, struggling to find words or follow conversations, and show changes in personality or behavior, such as increased apathy, social withdrawal, or irritability. As it advances, symptoms worsen, leading to significant memory loss, particularly of recent events and people's names, and a declining ability to perform routine tasks like managing finances or personal care. In later stages, individuals may become unaware of time and place, have difficulty recognizing relatives and friends, and require full-time assistance with activities of daily living.

Causes and risk factors

The most common underlying cause is Alzheimer's disease, accounting for an estimated 60-70% of cases, characterized by amyloid plaques and neurofibrillary tangles in the brain. Vascular dementia, often following strokes or damage to blood vessels in the brain, is another major cause. Other conditions include Lewy body dementia, associated with abnormal protein deposits called Lewy bodies, and frontotemporal dementia, which involves degeneration of the frontal lobe and temporal lobe. Significant risk factors include advanced age, a family history of the condition, cardiovascular disease, diabetes, smoking, physical inactivity, and depression. Less common causes can include Creutzfeldt-Jakob disease, Huntington's disease, and chronic alcohol abuse.

Diagnosis

There is no single test to confirm the syndrome; diagnosis is clinical and involves a comprehensive assessment. A detailed medical history is taken, often with information from a family member or close associate. Cognitive and neuropsychological tests, such as the Mini-Mental State Examination (MMSE) or the Montreal Cognitive Assessment (MoCA), evaluate memory, problem-solving, and language skills. Physical examination and neurological examination help rule out other conditions. Brain imaging techniques, including computed tomography (CT) and magnetic resonance imaging (MRI), are used to identify strokes, tumors, or other structural problems, while positron emission tomography (PET) scans can sometimes detect patterns of brain activity associated with specific types. Laboratory tests of blood may identify other potential causes like vitamin B12 deficiency or thyroid problems.

Management

While most causes are progressive and currently incurable, management focuses on improving quality of life and functioning. Pharmacological treatment may include cholinesterase inhibitors like donepezil or memantine, which can temporarily improve or stabilize symptoms in some individuals. Non-pharmacological approaches are crucial and involve cognitive stimulation therapy, structured physical activity, and creating a safe, supportive environment. Managing accompanying behavioral and psychological symptoms, such as agitation or psychosis, may require tailored behavioral strategies and, in some cases, careful use of medications under supervision from a psychiatrist. Support for caregivers, including education and respite care, is an essential component of care, with organizations like the Alzheimer's Association providing resources.

Epidemiology

It is a major and growing public health issue globally. According to the World Health Organization, over 55 million people were living with it worldwide in 2020, with nearly 10 million new cases diagnosed each year. It is a leading cause of disability and dependency among older people globally. Prevalence increases dramatically with age, affecting approximately 1-2% of people at age 65 and up to 30% by age 85. The total number of people affected is projected to rise to 78 million by 2030 and 139 million by 2050, driven largely by aging populations in countries like the United States, China, and India. The societal cost is immense, encompassing direct medical costs, social care, and informal care provided by family members.

History

Descriptions of severe memory loss in old age date back to ancient times, with philosophers like Plato and Aristotle commenting on the mental decline of the elderly. The term itself derives from the Latin *dement*, meaning "out of one's mind." In the early 20th century, German psychiatrist Alois Alzheimer first described the pathological features of the disease that bears his name after examining the brain of his patient Auguste Deter. Throughout the 20th century, distinctions between different types became clearer through the work of neurologists like Frederick Lewy and the development of modern brain imaging. The late 20th and early 21st centuries have seen increased public awareness, advocacy by groups like Alzheimer's Disease International, and significant, though still largely unsuccessful, research efforts to find disease-modifying treatments.

Category:Neurological disorders Category:Geriatrics Category:Psychiatry